当前位置: 首页 > 期刊 > 《医药产业资讯》 > 2019年第13期
编号:13380124
眼表疾病中转化生长因子—β1/Smads信号通路的研究进展(5)
http://www.100md.com 2019年5月5日 《中国医药导报》 2019年第13期
     [38] Choi SI,Kim BY,Dadakhujaev S,et al. Inhibition of TGFBIp expression by lithium:implications for TGFBI-linked corneal dystrophy therapy [J]. Invest Ophthalmol Vis Sci,2011,52(6):3293-3330.

    [39] Kim TI,Lee H,Hong HK,et al. Inhibitory Effect of Tranilast on Transforming Growth Factor-Beta Induced Protein in Granular Corneal Dystrophy Type 2 Corneal Fibroblasts [J]. Invest Ophthalmol Vis Sci,2015,34(8)950-958.

    [40] Davidson AE,Hayes S,Hardcastle AJ,et al. The pathogenesis of keratoconus [J]. Eye,2014,28(2):189-195.

    [41] Engler C,Chakravarti S,Doyle J,et al. Transforming growth factor-β signaling pathway activation in Keratoconus [J]. Am J Ophthalmol,2011,151(5):752-759.

    [42] riyadarsini S,McKay TB,Karamichos D,et al. Keratoconus in vitro and the key players of the TGF-β pathway [J]. Mol Vis,2015,21:577-588.

    [43] Sharif R,Hjortdal J,Sejersen H,et al. Human in Vitro Model Reveals the Effects of Collagen Cross-Linking on Keratoconus Pathogenesis [J]. Sci Rep,2017,7(1):12517.

    (收稿日期:2018-10-31 本文編辑:封 华), 百拇医药(王亚卉 李青松 符之瑄)
上一页1 2 3 4 5